Skip to main content

Universal Search

for 'emiil'

  • Presentations

  • Monday, June 26, 2023
  • 15:30 – 15:45 ET
    OC 43.4 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: interim analysis of the non-interventional study EMIIL

    Presenting Author: Johannes Oldenburg, MD (he/him/his) – University Clinic Bonn AöR, Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany

    Co-Author: Carmen Escuriola-Ettingshausen, MD – Haemophilia Centre Rhine-Main, Mörfelden-Walldorf, Germany

    Co-Author: Pierre Fontana, MD PhD (he/him/his) – Division of Angiology and Haemostasis, University Hospitals of Geneva, Switzerland

    Co-Author: Swee Wenning – SRH Kurpfalzkrankenhaus, Heidelberg, Germany

    Co-Author: Christian Pfrepper, MD – Division of Hemostaseology, University Hospital Leipzig, Germany

    Co-Author: Bianca Heidersdorf – Roche Pharma AG, Grenzach-Wyhlen, Germany

    Co-Author: Patrick Udvardi – Roche Pharma Schweiz AG, Basel, Switzerland

    Co-Author: Manuela Albisetti – University Children’s Hospital Zurich, Zurich, Switzerland

    Hemophilia and Rare Bleeding Disorders